CHORMAN THOMAS E sold $18K of SXI
CHORMAN THOMAS E sold 50 shares of STANDEX INTERNATIONAL CORP/DE/ (SXI) at $355.51 on 2026-07-01 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
A director’s planned open-market sale provides limited incremental information about company performance; it mainly updates insider activity records.
Market read
Primarily relevant for insider-trading monitoring; not a catalyst for repricing absent other fundamental news.
What to watch
The transaction size is small and explicitly tied to a 10b5-1 plan, reducing interpretability versus unscheduled sales.
Background
The article is an SEC Form 4 insider transaction disclosure for STANDEX INTERNATIONAL CORP/DE (SXI).
Ticker impact
SEC Form 4 shows director Thomas E. Chorman sold 50 shares of STANDEX INTERNATIONAL at $355.51 on 2026-07-01 under a 10b5-1 plan.
Minimal impact; any effect should be short-lived and outweighed by broader market factors.
The filing is a small, planned insider sale (50 shares) with no accompanying guidance, deal, or regulatory action.
Market effects
No sector read-through; this is a single-company insider transaction.
None indicated.
None indicated.
Counterpoint
Even planned sales can coincide with personal liquidity needs; traders may still watch for follow-on insider activity or unusual volume around the same period.
Key entities
- issuerSTANDEX INTERNATIONAL CORP/DE
Subject of the Form 4 insider transaction disclosure (SXI).
- insiderCHORMAN THOMAS E
Director who sold 50 shares on 2026-07-01 under a Rule 10b5-1 plan.
